Filed: 4/14/2023ACC: 0001104659-23-045575
📋 What this filing means
KINNEVIK AB (PUBL) filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $74.55M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$74.55M
Total AUM (reported)
12.27M
Total Shares
Allocation by class
CL A SHS$74.55M100.0%
Portfolio Concentration
Top 3$74.55M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 12.27M
Sole
Full voting authority
12.27M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other2
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
Recursion Pharmaceuticals, Inc.
DFNDShares7.65M
TypeSH
Market value$51.05M
68.47%
Sole
7.65M
Shared
0.00
None
0.00
Babylon Holdings Ltd
DFNDShares4.62M
TypeSH
Market value$23.50M
31.53%
Sole
4.62M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc.DFND | CL A SHS | 7.65M | SH | $51.05M 68.47% | 7.65M | 0.00 | 0.00 |
Babylon Holdings LtdDFND | CL A SHS | 4.62M | SH | $23.50M 31.53% | 4.62M | 0.00 | 0.00 |